Nanox AI

Nanox AI is the AI medical imaging software business within Nanox, focused on analyzing routine CT scans to identify incidental or previously undetected findings associated with chronic disease. The business originated as Zebra Medical Vision and was acquired by Nano-X Imaging in 2021, after which it was rebranded as Nanox AI. Its commercial product suite includes FDA-cleared and CE-marked algorithms for coronary artery calcification assessment, liver density analysis, and bone and vertebral abnormality detection, integrated into radiology workflows, PACS, EMR, and reporting systems. Nanox AI is positioned as part of Nanox’s broader end-to-end imaging platform alongside imaging hardware, cloud infrastructure, and teleradiology services, with a preventive-care and population-health orientation.